Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Krystal Biotech, Inc. (KRYS) had Gross Margin of 92.54% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$96.04M |
|
$38.33M |
|
$7.17M |
|
$88.88M |
|
$56.73M |
|
$39.31M |
|
$7.47M |
|
$46.77M |
|
$46.77M |
|
$38.33M |
|
$38.33M |
|
$38.33M |
|
$38.33M |
|
$39.31M |
|
$40.85M |
|
28.91M |
|
29.75M |
|
$1.33 |
|
$1.29 |
|
| Balance Sheet Financials | |
$841.35M |
|
$150.39M |
|
$297.05M |
|
$1.14B |
|
$86.90M |
|
-- |
|
$10.85M |
|
$97.75M |
|
$1.04B |
|
$1.04B |
|
$1.04B |
|
28.93M |
|
| Cash Flow Statement Financials | |
$83.70M |
|
$-65.29M |
|
$-10.67M |
|
$344.87M |
|
$353.83M |
|
$8.96M |
|
$27.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
92.54% |
40.93% |
|
40.93% |
|
-- |
|
48.70% |
|
39.91% |
|
$76.03M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.23 |
|
0.86 |
|
104.43 |
|
3.68% |
|
3.68% |
|
3.37% |
|
3.68% |
|
$35.97 |
|
$2.56 |
|
$2.81 |
|